X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3643) 3643
Publication (553) 553
Book / eBook (44) 44
Book Chapter (44) 44
Book Review (42) 42
Conference Proceeding (10) 10
Magazine Article (10) 10
Dissertation (3) 3
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3093) 3093
male (1801) 1801
female (1705) 1705
index medicus (1491) 1491
adult (1392) 1392
middle aged (1181) 1181
psychiatry (1012) 1012
neurocognitive disorders - drug therapy (825) 825
neurosciences (757) 757
aged (691) 691
neuropsychological tests (686) 686
hiv (588) 588
cognition (543) 543
neurocognitive disorders - psychology (506) 506
neurocognitive disorders - diagnosis (485) 485
clinical neurology (480) 480
neurocognitive disorders (466) 466
schizophrenia (462) 462
article (453) 453
adolescent (434) 434
immunology (382) 382
infectious diseases (382) 382
antiretroviral therapy (349) 349
neurology (333) 333
neurocognitive disorders - etiology (332) 332
neurocognitive impairment (325) 325
dementia (320) 320
schizophrenia - drug therapy (317) 317
brain (311) 311
cognition disorders - etiology (303) 303
analysis (301) 301
neurocognitive deficits (299) 299
animals (295) 295
virology (290) 290
schizophrenic psychology (288) 288
hiv infections - complications (285) 285
human immunodeficiency virus--hiv (275) 275
antipsychotic agents - therapeutic use (269) 269
risk factors (264) 264
memory (259) 259
child (254) 254
pharmacology & pharmacy (254) 254
cognitive impairment (249) 249
hiv infections - drug therapy (248) 248
young adult (246) 246
cognitive ability (243) 243
central-nervous-system (238) 238
psychology (238) 238
hiv infection (233) 233
psychiatric status rating scales (233) 233
care and treatment (231) 231
cognition disorders - diagnosis (231) 231
depression (229) 229
treatment outcome (228) 228
impairment (227) 227
human-immunodeficiency-virus (219) 219
health aspects (218) 218
research (218) 218
neurocognitive function (211) 211
biomedicine (208) 208
diagnosis, differential (201) 201
hiv-associated neurocognitive disorders (180) 180
follow-up studies (175) 175
cognition disorders - psychology (173) 173
magnetic resonance imaging (173) 173
medicine & public health (173) 173
neuropsychology (173) 173
performance (172) 172
neurocognitive disorders - physiopathology (165) 165
antiviral agents (164) 164
drug therapy (162) 162
aids (161) 161
neurocognitive disorders - therapy (161) 161
alzheimers-disease (158) 158
cerebrospinal-fluid (157) 157
hiv infections - psychology (156) 156
infection (155) 155
disorders (153) 153
schizophrenia - diagnosis (152) 152
prevalence (151) 151
executive function (148) 148
drug therapy, combination (147) 147
highly active antiretroviral therapy (145) 145
bipolar disorder (141) 141
bipolar disorder - drug therapy (141) 141
mental disorders (140) 140
quality-of-life (139) 139
cross-sectional studies (137) 137
disease (137) 137
quality of life (136) 136
comorbidity (135) 135
cognition disorders - drug therapy (134) 134
virus diseases (134) 134
psychology, clinical (133) 133
active antiretroviral therapy (132) 132
brain - pathology (132) 132
hiv-1 (132) 132
j ve psychiatry (132) 132
therapy (132) 132
psychotropic drugs - therapeutic use (128) 128
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (38) 38
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Providence Healthcare - Stacks (3) 3
UofT at Mississauga - Stacks (3) 3
Baycrest Hospital - Stacks (2) 2
Holland Bloorview Kids Rehabilitation - Stacks (2) 2
Online Resources - Online (2) 2
Baycrest Hospital - Missing (1) 1
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Missing (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
OISE - Lost (1) 1
Robarts - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3362) 3362
German (205) 205
Russian (68) 68
French (40) 40
Polish (12) 12
Italian (7) 7
Czech (6) 6
Spanish (6) 6
Japanese (4) 4
Portuguese (4) 4
Swedish (4) 4
Dutch (3) 3
Chinese (2) 2
Slovak (2) 2
Croatian (1) 1
Norwegian (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Epilepsia, ISSN 0013-9580, 08/2013, Volume 54, Issue 4, pp. 44 - 60
Summary Many symptoms of neurologic or psychiatric illness—such as cognitive impairment, depression, anxiety, attention deficits, and migraine—occur more... 
Biomarkers | Therapy | Animal models | Comorbidity | Epilepsy | DEPRESSIVE-LIKE BEHAVIOR | TEMPORAL-LOBE EPILEPSY | GENETIC ABSENCE EPILEPSY | ENVIRONMENTAL ENRICHMENT | KETOGENIC DIET | CLINICAL NEUROLOGY | TRAUMATIC BRAIN-INJURY | EARLY-LIFE SEIZURES | SPATIAL MEMORY | INDUCED STATUS EPILEPTICUS | IMMATURE RATS | Drugs, Investigational - adverse effects | Cognition Disorders - chemically induced | Humans | Drugs, Investigational - therapeutic use | Depressive Disorder - drug therapy | Neurocognitive Disorders - psychology | Anxiety Disorders - chemically induced | Migraine Disorders - chemically induced | Neurocognitive Disorders - drug therapy | Depressive Disorder - chemically induced | Quality of Life - psychology | Anxiety Disorders - drug therapy | Drug Evaluation, Preclinical | Cognition Disorders - psychology | Disease Models, Animal | Attention Deficit Disorder with Hyperactivity - chemically induced | Epilepsy - psychology | Translational Medical Research | Neurocognitive Disorders - diagnosis | Neurocognitive Disorders - chemically induced | Cognition Disorders - drug therapy | Anxiety Disorders - psychology | Attention Deficit Disorder with Hyperactivity - drug therapy | Drug Discovery | Migraine Disorders - drug therapy | Epilepsy - diagnosis | Cognition Disorders - diagnosis | Animals | Migraine Disorders - psychology | Attention Deficit Disorder with Hyperactivity - psychology | Epilepsy - drug therapy | Depressive Disorder - psychology | Analysis | Medical research | Quality of life
Journal Article
Acta Psychiatrica Scandinavica, ISSN 0001-690X, 09/2013, Volume 128, Issue 3, pp. 149 - 162
Journal Article
Journal of Neurology, ISSN 0340-5354, 08/2009, Volume 256, Issue 3, pp. S293 - S296
Journal Article
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 06/2013, Volume 13, Issue 1, pp. 261 - 261
Background: HIV infection, anti-tuberculosis and efavirenz therapy are associated with neuropsychological effects. We evaluated the influence of rifampicin... 
CYP2B6 | Rifampicin | Tuberculosis | HIV | CNS | Ugandans | Efavirenz | Neuropsychiatric toxicity | Antiretroviral therapy | INFECTIOUS DISEASES | ANTITUBERCULAR THERAPY | SECONDARY METABOLISM | DRUG CONCENTRATIONS | HIV-1-INFECTED PATIENTS | BLOOD-BRAIN-BARRIER | NEUROPSYCHIATRIC ADVERSE EVENTS | PLASMA EXPOSURE | NEUROCOGNITIVE DISORDERS | INFECTED PATIENTS | Memory Disorders - virology | Prospective Studies | Humans | Mental Disorders - metabolism | Aryl Hydrocarbon Hydroxylases - genetics | Hallucinations - virology | Memory Disorders - metabolism | Uganda - epidemiology | HIV Infections - psychology | Male | Sleep Arousal Disorders - virology | HIV Infections - microbiology | Cytochrome P-450 CYP3A - genetics | Benzoxazines - pharmacokinetics | Sleep Arousal Disorders - metabolism | Tuberculosis - drug therapy | Adult | Benzoxazines - blood | Female | Rifampin - therapeutic use | Anti-HIV Agents - blood | Mental Disorders - virology | Tuberculosis - metabolism | Cognitive Dysfunction - drug therapy | Hallucinations - drug therapy | Cognitive Dysfunction - virology | Anti-HIV Agents - adverse effects | Cognitive Dysfunction - metabolism | Gene Frequency | Kaplan-Meier Estimate | Benzoxazines - adverse effects | Hallucinations - metabolism | Mental Disorders - microbiology | Antiretroviral Therapy, Highly Active | Tuberculosis - virology | Memory Disorders - drug therapy | Sleep Arousal Disorders - drug therapy | Mental Disorders - drug therapy | Anti-HIV Agents - pharmacokinetics | Antibiotics, Antitubercular - therapeutic use | HIV Infections - drug therapy | Cytochrome P-450 CYP2B6 | HIV Infections - metabolism | Sleep disorders | Usage | Hallucinations and illusions | Research | Analysis | Medical research | Antiviral agents | Care and treatment | Nervous system diseases | Pharmacogenetics | Cytochrome P-450 | HIV patients | HIV (Viruses) | Highly active antiretroviral therapy | Sleep | Insomnia | Medicine, Experimental | Health aspects | Rifampin | Plasma | Genotype & phenotype | Health sciences | Brain research | Blood-brain barrier | Human immunodeficiency virus--HIV | Drug therapy | Patients | Psykiatri | Farmakologi och toxikologi | Klinisk medicin | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | Infektionsmedicin
Journal Article
Journal Article